Stephen Hallenbeck

Stephen Hallenbeck is a Managing Director at Hildred Capital Management. He previously served as the Director of Private Equity at Hildred Capital Partners, where he was responsible for sourcing, evaluating, executing and managing investment opportunities within the Hildred private equity portfolio. Since joining HCP in 2016, Mr. Hallenbeck led six majority buyout acquisitions, arranging total debt and equity financings in an aggregate of $450 million. In connection with his oversight at Hildred, Mr. Hallenbeck serves on the Board of Directors for Project Natural, a leading supplier of natural therapeutic consumer healthcare products; DermCare, a dermatology practice management company; SportsMed, a physical therapy practice management company; and Crown Laboratories, a premier dermatology, aesthetic and skincare product business. In addition to his role at HCM, Mr. Hallenbeck serves on the Board of Directors and Financial Sustainability Committee of the Triangle Fund, a community and youth-focused non-profit organization based in upstate New York.

Prior to joining Hildred, Mr. Hallenbeck worked at Deutsche Bank Securities from 2009 to 2016, where he most recently worked in the Financial Sponsors Group. In this role, Mr. Hallenbeck identified and evaluated leveraged acquisitions and capital markets financings for both prospective and current portfolio companies of private equity firms. Prior to his time in the Financial Sponsors Group, Mr. Hallenbeck spent time as a member of Deutsche Bank’s Healthcare Investment Banking team, focusing on M&A, debt and equity transactions for both private and public companies within the sector.

Mr. Hallenbeck received a B.A. in Economics with honors from Vanderbilt University.